Patrick Sherwood on the Power of a Simulation-based, Probabilistic Pacing Model

Patrick Sherwood on the Power of a Simulation-based, Probabilistic Pacing Model

GroveStreet’s Patrick Sherwood is featured in the latest edition of Private Equity Findings published by the Coller Research Institute. In an article delving into a new model for private equity pacing and cash flow forecasting, Patrick and Alex Billias of Bella Private Markets discuss the merits of moving beyond widely used deterministic approaches such as those developed at Yale, to a probabilistic model drawing on actual cash flow data and arming allocators with a range of potential outcomes instead of sometimes misleading and often misunderstood point estimates. The new model developed by Bella and GroveStreet retains the core principles and intuition of the Yale model but is powered by simulation-based computations and actual portfolio data. Read more about the new model here.

Learn more about us or reach out to schedule a meeting.

Redpoint’s Logan Bartlett explores the future of personalized knowledge with Perplexity.ai CEO

Redpoint’s Logan Bartlett explores the future of personalized knowledge with Perplexity.ai CEO

Aravind Srinivas, Co-Founder and CEO of Perplexity.ai, is in the vanguard of the AI revolution. Srinivas worked at Deepmind, Google, and OpenAI before starting Perplexity, an AI-chatbot ‘answer engine’ featuring natural language responses and citations, brazenly competing with Google. In the podcast Bartlett and Srinivas discuss how Google lacks alignment between its shareholders, its advertisers, and its core search users, therefore stifling innovation and leaving an opening for an AI-native entrants like Perplexity.ai to disrupt the current paradigm. GroveStreet has been a Redpoint investor since 2000.

Listen to this thought-provoking episode here, or wherever you get your podcasts.

Learn more about us or reach out to schedule a meeting.

New Heritage Realizes Investment in Rhythmlink

New Heritage Realizes Investment in Rhythmlink

New Heritage exits its investment in Rhythmlink, the market-leading designer and manufacturer of single-use brain health and neurodiagnostic electrodes. New Heritage first invested in Rhythmlink in February 2019 and sold the Company to Graham Partners after successfully executing a strategic and operational growth plan that sets up Rhythmlink for continued expansion. GroveStreet first become a New Heritage LP in 2014. Read more about the deal here: https://www.newheritagecapital.com/new-heritage-capital-exits-investment-in-portfolio-company-rhythmlink/